chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a female consumer of unknown age refers to herself. On 10-SEP-2012 the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported) subcutaneously. On the same day the patient had a sensation at the injection site like a biting. The patient stated itching, and burning at the site. The patient sought for medical attention by seeing her physician who advised her to take BENADRYL. The outcome was unknown. Additional information is not expected.
still dealing with pain on my forehead; This case was reported by a consumer via interactive digital media and described the occurrence of forehead headache in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received shot 8 years before reporting day).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced forehead headache. On an unknown date, the outcome of the forehead headache was recovered/resolved.   It was unknown if the reporter considered the forehead headache to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient got a shot 8 years ago and still came down with it. The patient's physician send him/her to get the new vaccine shot a series of 2 Shots. The patient received Shingles vaccine and experienced pain on forehead. For tolerance of 2nd dose refer case US2021AMR094080.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR094080:same reporter
I got extremely tired, congested on 1/11 went to see PCP. I tested for Covid(results positive) and was told to continue taking Humira. I was super exhausted for days with cough.
Slept for two days; This spontaneous case was reported by an other caregiver and describes the occurrence of HYPERSOMNIA (Slept for two days) in a 101-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced HYPERSOMNIA (Slept for two days). In February 2021, HYPERSOMNIA (Slept for two days) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided.  Treatment information not provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Telephone contact report received on 29-APR-2021 contain no new information
c/o swelling lt arm, in lt arm warm to touch;c/o weakness bilateral legs;c/o not feeling well;feel like have the flu;pt devel cold sweats during school today approx 1PM (arm soreness & leg weakness devel @ same time;T101 330PM on 4MAR98 w/
3:30 2 hours after injection, client reports "feeling funny", extremely nauseated, light headed and "foggy". BP 174/104, irregular pulse. 3:40 BP 156/90, irregular pulse, nausea and light headedness present, but less. 3:50 BP 148/90, irregular pulse, transported by friend to Dr. Client reports BP 174/104 in physician's office, given Veralan and observed for 30-40 minutes.
RESIDENT COMPAINED OF PAIN TO BILATERAL  THIGHS AND LOWER BACK SENT TO ER.  NOTIFIED BY ER,  PATIENT HAS BLOOD CLOTS IN ABDOMIN
Starting evening of shot (approximately 6 hours later) tingling in arm from inj site to fingers. Swelling of arm at inj site and surrounding areas. As of 9 AM 9/3/14 tingling still from inj site to wrist. No fingers. Swelling better. Ice, BENADRYL.
Information has been received a nurse concerning a female patient who was vaccinated IM with a first dose of Gardasil. Almost immediately after receiving the vaccine, the patient fainted. Medical attention was not sought because the patient was in the office at the time of the occurrence. It was reported that the patient recovered shortly after and left the office feeling fine. No product quality complaint was involved. Additional information has been requested.
Moderate Pain in right armpit radiated to sternum and lower rib cage on right side. Sporadic headache. Sweating but no fever (anxiousness perhaps??). Felt fine next day, some soreness at injection site remained.
got a pain started out feeling like mid back pain, and became more of a chest pain. It was an aching and stabbing pain heavy to the chest.; got a pain started out feeling like mid back pain, and became more of a chest pain. It was an aching and stabbing pain heavy to the chest.; got a pain started out feeling like mid back pain, and became more of a chest pain. It was an aching and stabbing pain heavy to the chest.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the arm right on 04May2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, asthma, depression, anxiety, thyroid disorder, scoliosis and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), bupropion hydrochloride (WELLBUTRIN), methylphenidate hydrochloride (RITALIN), solifenacin succinate (VESICARE) and tiotropium bromide monohydrate (SPIRIVA); all from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm right on 13Apr2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 05May2021 at 14:00, the following day after the shot, about 30 hours after shot, the patient started out feeling like mid back pain and became more of a chest pain. The patient fell asleep for two hours and was woken up by the chest pain worsening. Lasted about four hours. It was an aching and stabbing pain heavy to the chest. Therapeutic measures were taken as a result of the events and included treatment with 325 ASPIRIN. The clinical outcome of the events got a pain started out feeling like mid back pain, became more of a chest pain and aching and stabbing pain heavy to the chest was recovered on 05May2021.  No follow-up attempts are needed. No further information is expected.
my arm is very sore; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   On 08-SEP-2023, the patient received RSV vaccine. In SEP-2023, an unknown time after receiving RSV vaccine, the patient experienced pain in arm (Verbatim: my arm is very sore).  The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to RSV vaccine.     It was unknown if the company considered the pain in arm to be related to RSV vaccine.   Additional Information: GSK receipt date: 09-SEP-2023 This case was reported the patient via interactive digital media. The patient received the dose yesterday (day before reporting) and arm was very sore. Follow-up not possible as no contact details provided.
After got in car had difficulty restriction throat like shot throat with NOVOCAINE & base of tongue.  Drove self to fire dept.  BP 220/90.  Sent to hospital trembling inside.  No sweating, no rash, no difficulty breathing.
Mild headache following second shot that has lasted 3 months. Dreams more frequent, vivid, very different than prior to vaccine.
Migraine headaches; Neck pain for eight days; Mouth sores; Felt lethargic; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headaches), NECK PAIN (Neck pain for eight days), ORAL PAIN (Mouth sores) and LETHARGY (Felt lethargic) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine headaches), NECK PAIN (Neck pain for eight days), ORAL PAIN (Mouth sores) and LETHARGY (Felt lethargic). At the time of the report, MIGRAINE (Migraine headaches), NECK PAIN (Neck pain for eight days), ORAL PAIN (Mouth sores) and LETHARGY (Felt lethargic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken by the patient were not provided. Treatment information was not provided.
Blotchy, erythematous, macular, papular, rash, measles type rash to trunk extremities, face and neck.
On December 27, 2021 between 12-04:00PM EST I started sneezing consecutively non-stop at least 3-4 times, a short break no more than 30 minutes and I just did that for nearly two days. As that weaned off, I had congestion for like a week. I tried Zicam but that didn't help. By the 2nd or 3rd of January I went to an urgent care locally to be tested. I had a Rapid and PCR test and both were negative. I felt bad enough I felt I should be tested.
tested + for COVID-19 on 5/13/2021 - symptomatic; Dialysis patient
pt recvd vax & devel myalgia, sinusitis & upper respiratory infect, coughing up green stuff; pt interpreted these symptoms as lack of effect; pt dx w/ allergies versus prolonged viral infection;
Patient became apneic, cyanotic, and had bradycardia into 40s. O2sats less than 10%. Infant did not respond to stimulation. PPV started at 100% FiO2. CPAP initiated and continued. Infant placed on NIPPV at 0700 2/18.
The patient received a dose from a vial more than 30 days on the fridge; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received a dose from a vial more than 30 days on the fridge) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received a dose from a vial more than 30 days on the fridge) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 13-Aug-2021, EXPIRED PRODUCT ADMINISTERED (The patient received a dose from a vial more than 30 days on the fridge) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. The vial was initially stored in the refrigerator on 20-Apr-2021.    Most recent FOLLOW-UP information incorporated above includes: On 05-Nov-2021: Follow-up information received contains no new information.
Left arm, intense heat, red rash, swollen, looks like large hive. 4 or 5 inches. Looked online, taking Benadryl and using hydrocortisone cream all day, 1/31/2021. Not as swollen as when it started.
This is an unconfirmed spontaneous report from a lawyer referring to a 40 year old female who claims to have experienced sharp, debilitating pain in most of her joints on the right side of her body after the 2nd dose of Lymerix. On an unspecified date, the pt received her 1st dose of Lymerix with no reported events. In August, 1999, the pt received her 2nd dose of Lymerix  and some time after the shot (exact date not provided), the pt experienced sharp, dibilitating pain in most of her joints on the right side of her body (in her foot, hip, shoulder, hand and neck). The pain was reported to be "like nothing she had ever experienced" and the pt has been considered incapacitated. The most recent information received on 2/17/2000, reports that the symptoms are ongoing. Additional information has been requested.
I82.409 ACUTE DVT, UNSPECIFIED VEIN 3/28/2023 HX OF DIABETIC FOOT ULCER
Very very sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very very sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very very sick). At the time of the report, ILLNESS (Very very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant product use was reported. No treatment information was provided.  The reporter called to inform that their relative was very very sick.   Most recent FOLLOW-UP information incorporated above includes: On 12-Nov-2021: Follow-up was received and contains contact information. Updated the contact information. On 12-Nov-2021: Follow-up information included No new information.
She got her vaccine and had a rapid rise in BP and pulse, and ended up in the UC.  From there she was sick and down for 8 days with body aches, prickly feeling all over her skin, just general fatigue and feeling sick.  At 7 days after the vaccine she started with some arrhythmia problems, and had acute anxiety.  Muscles/ribs very sore to touch.  Whole upper body is inflamed.  Those symptoms continued for 7 weeks, but the inflammation decreased in the muscles/joints diminished.   7 weeks after receiving the vaccine because of the acute inflammation and anxiety she ended up 3 nights and days with no sleep.  She went to the UC again and they gave her something for that.  She is still having heart arrhythmias as her heart is inflamed.  Then starting the 1st week in April she started getting sick.  The arrhythmias increased to palpitations to PVC's that began to increase.  She became dizzy, light headed at times, the nausea started, the palpitations were painful and then went to see a cardiologist.  He is trying to get medications to stop the palpitations.  So far they are waiting for the medication to take effect.  She has been down for 5 days, she is weak, dizzy when she is up.  Her BP and pulse are stable, EKG is normal.  She is also having what she is calling surges and/or storms, acute anxiety storms that rush through her body which makes her body feel like fire rushing through her body, acute panic.  It causes her to have to lie down and curl up, fatigue, dizziness and nausea to go with that.  It does subside slowly, but takes about 2 hours.  She has ongoing symptoms that are increasing in severity and are trying to treat the symptoms, but so far just waiting for things to work    She has never been sick, never had anxiety issues.  There is nothing in her environment that would cause these reactions.   She believes that the storms are being brought on by the storm surges that are coming and going.
This is a spontaneous report from a contactable physician via Pfizer sales representative. A 17-year-old female patient of unspecified ethnicity received TRUMENBA (lot number J28923) intramuscular on the left deltoid on 20Aug2015 at 16:30 at single dose, on unknown date. Relevant medical history included Hashimoto's thyroiditis and hypothyroidism for several years, well controlled on Levothyroxine. Concomitant medication included levothyroxine sodium (manufacturer unknown) at 75 mg daily for hypothyroidism. The patient underwent a TB skin test (manufactured by Sanofi Pasteur) on 23Jul2015. She got an unspecified vaccine on 14Jul2014 without issue. The day after the vaccination, on 21Aug2015, the patient developed bruising that extended from shot area to elbow, considered not serious. The patient recovered from the event on 23Aug2015. The physician reported that the patient provided to him/her information regarding the reported adverse event with the use of the vaccine. The physician considered the Pfizer vaccine had a causal effect to the adverse event. Follow up (13Oct2015): New information reported from the same contactable physician includes: patient's age, details of the vaccine, medical history, concomitant medication, lab data, outcome, physician's causality assessment and seriousness. Follow-up attempts completed. No further information expected. Follow-up (21Oct2015): This is a follow-up report combining information from duplicate reports 2015293929 and 2015291938. The current and all subsequent information will be reported under manufacturer report number 2015291938. Follow-up attempts completed. No further information expected.
Immediately after administration, patient became pale diaphoretic, lost consciousness, had jerking body movements, maintained pulse and airway. Once regained consciousness, vomited 3 times. Pt was given pepcid with fathers consent. After about 10 minutes started to complain of tightness of chest, short of breath. With consent from father administered 25 mg of benadryl. Monitored for 30 minutes. Patient status returned to baseline at the end of the 30 minutes observation. encouraged to follow up with pc prior to next vaccination to weigh the risk and benefits. Afterwards, dad said patient had reactions like this in past with vaccination. Asked multiple times if wanted EMS called or transport to medical facility. Declined by father.
Fussiness and lack of appetite for 3 days culminating in fever (102*) and lethargy on the 3rd day. No other symptoms.
Increased Fatigue and Uneasiness with breathing. Uneasiness with breathing continued to be bothersome as of today
Dose 1 Pfizer (day 1) Dose 2 Moderna (day 27)  Notified Doctor, educated patient on mRNA technology
raised red triangular-shaped rash on left arm, measures 33mm X 41mm.
injection pain; Diarrhea; nausea; weakness; trembling; light headed; loss of appetite; headache; tiredness; loss of balance; feeling unwell; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient received BNT162b2 (BNT162B2), on 07Apr2022 at 13:00 as dose 1, single (Lot number: Fk9894) at the age of 67 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes mellitus" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; ATORVASTATIN; GLIPIZIDE; FAMOTIDINE; BENTYL. The following information was reported: DIARRHOEA (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "Diarrhea"; MALAISE (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "feeling unwell"; HEADACHE (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering"; VACCINATION SITE PAIN (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "injection pain"; DIZZINESS (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "light headed"; DECREASED APPETITE (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "loss of appetite"; BALANCE DISORDER (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "loss of balance"; NAUSEA (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering"; FATIGUE (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "tiredness"; TREMOR (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "trembling"; ASTHENIA (non-serious) with onset 07Apr2022 at 16:00, outcome "recovering", described as "weakness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site pain, diarrhoea, nausea, asthenia, tremor, dizziness, decreased appetite, headache, fatigue, balance disorder, malaise.  Additional information: The clinical course was reported as the patient had not other vaccine in 4 weeks. Patient had other medication in 2 weeks with metformin, atorvastatin, glipizide, famotidine and bentyl. Patient had covid prior to vaccination and had covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Pain in arm, tingling all down left arm where shot was administered, numbness in hands and fingers, numbness on entire left side of body.
pt recv vax 9APR97 & 4MAY97 pt devel chickenpox consisting of approx 30-40 lesions, mainly on back & arms;pt also exp sl itching;pt recovered;
Patient's arm is sore, little swollen and red and she said she itches a little.
Beginning 4-2 to present: nausea & vomiting, hives over entire body, lethargy
no adverse event; Improperly stored administered vaccines; This spontaneous report was received from a registered nurse and from vaccine coordinator and refers to a patient of unknown age and gender. The patient's concurrent conditions, historical conditions and concomitant medications were not reported.   On 09-SEP-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U010395 expiration date 01-APR-2023 (dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). The suspect vaccine was stored in a temperature from -10 degree Celsius (C) to 8 C for 5 hours and 10 minutes. There was previous temperature excursion - the vaccine was stored in a temperature from -10 C to 8 C for 8 hours and 41 minutes and for 3 hours and 35 minutes. No additional adverse events were reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA006537: US-009507513-2109USA006583: US-009507513-2109USA006584: US-009507513-2109USA006585: US-009507513-2109USA006586: US-009507513-2109USA006587: US-009507513-2109USA006588: US-009507513-2109USA006589: US-009507513-2109USA006590: US-009507513-2109USA006591: US-009507513-2109USA006592: US-009507513-2109USA006593: US-009507513-2109USA006594: US-009507513-2109USA006595: US-009507513-2109USA006596: US-009507513-2109USA006597: US-009507513-2110USA005066: